Pelthos Therapeutics Inc. (PTHS) — Defensive Interval Ratio

Latest as of December 2025: 124 days

Pelthos Therapeutics Inc. (PTHS) has a Defensive Interval Ratio of 124 days as of December 2025. Defensive assets of $8.86 Million (cash $-, short-term investments $-, receivables $8.86 Million) cover 124 days of daily cash needs of $71.21K/day. For the complete balance sheet picture, see Pelthos Therapeutics Inc. (PTHS) total assets.

Defensive Interval Ratio

124 days
Days of operational coverage

Defensive Assets

$8.86 Million
Cash + ST Investments + Receivables

Daily Cash Need

$71.21K
Current Liabilities ÷ 365

Current Liabilities

$25.99 Million
USD

Pelthos Therapeutics Inc. Defensive Interval Ratio (2024–2025)

This chart shows how Pelthos Therapeutics Inc.'s Defensive Interval Ratio has evolved across 2 annual periods from 2024 to 2025. As of December 2025, the ratio stands at 124 days, meaning defensive assets of $8.86 Million can fund 124 days of operations without new revenue. Read Pelthos Therapeutics Inc. balance sheet liabilities for a breakdown of total debt and financial obligations.

Annual Defensive Interval Ratio for Pelthos Therapeutics Inc. (2024–2025)

The table below presents the year-by-year Defensive Interval Ratio for Pelthos Therapeutics Inc. from 2024 to 2025, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2025 124 days $8.86 Million $71.21K/day $- $- ▲ +121 days
2024 4 days $40.40K $11.19K/day $- $-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)